Second, given that ACE-2-mediated function is known to abnormally increase mucosal permeability and GI motility [27, 28], SARS-CoV-2 would have bound to the ACE-2 receptor in the GI tract among patients who developed IBS in this study. Here, ACE2 is linked to irritable bowel syndrome.